Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5117]
News [14821]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )
5 Jun 2017
Immunotherapy may slow the growth of malignant pleural mesothelioma
Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France
Immunotherapy may slow the growth of malignant pleural mesothelioma ( Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France )
5 Jun 2017
Immunotherapy for mesothelioma could be on the horizon
Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France
Immunotherapy for mesothelioma could be on the horizon ( Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France )
5 Jun 2017
CAR T-cell therapy can be used to send multiple myeloma into lasting remission
Dr Wanhong Zhao - Xi’an Jiaotong University Hospital, China
CAR T-cell therapy can be used to send multiple myeloma into lasting remission ( Dr Wanhong Zhao - Xi’an Jiaotong University Hospital, China )
5 Jun 2017
Alectinib eclipses crizotinib for ALK positive lung cancer
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Alectinib eclipses crizotinib for ALK positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2017
Adding a second HER2 targeted medicine may lower chance of invasive breast...
Dr Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Adding a second HER2 targeted medicine may lower chance of invasive breast cancer ( Dr Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
5 Jun 2017
Targeted sequencing in endocrine refractory breast cancer
Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada
Targeted sequencing in endocrine refractory breast cancer ( Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada )
5 Jun 2017
Treating BRCA breast cancer with PARP inhibition
Dr Mika Sovak - AstraZeneca, Cambridge, UK
Treating BRCA breast cancer with PARP inhibition ( Dr Mika Sovak - AstraZeneca, Cambridge, UK )
4 Jun 2017
Relieving spinal cord compression symptoms with a single radiation treatment
Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom
Relieving spinal cord compression symptoms with a single radiation treatment ( Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom )
4 Jun 2017
Halving duration of ADT for high risk prostate cancer patients
Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Halving duration of ADT for high risk prostate cancer patients ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
4 Jun 2017
New personalised therapies for lung cancer
Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA
New personalised therapies for lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA )
4 Jun 2017
Findings of a phase I/II study of nivolumab in patients with virus-associated...
Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France
Findings of a phase I/II study of nivolumab in patients with virus-associated tumours ( Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France )
4 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation